fda changes to semaglutide shortage ends as sets deadline for compounders Why you will no longer

Designed for consistent and repeatable measurement in laboratory settings

325(14): p

Several Canadian and international generic manufacturers have submitted applications to Health Canada, including: Sandoz - with multiple semaglutide formulation applications Teva - applications for various strengths Apotex - submissions currently under regulatory review Taro Pharmaceuticals - generic semaglutide applications Vimy Pharma - Canadian-manufactured generic applications Market Impact Considerations Industry analysts expect generic semaglutide to be priced significantly below current brand-name medications

Voora S, Adey DB